{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:30:53Z","timestamp":1784694653062,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00380-018-1279-1","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T08:17:22Z","timestamp":1539332242000},"page":"597-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9577-6586","authenticated-orcid":false,"given":"Hidekatsu","family":"Fukuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Wakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ohte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"1279_CR1","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","volume":"33","author":"RS Vasan","year":"1999","unstructured":"Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D (1999) Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33:1948\u20131955","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:251\u2013259","journal-title":"N Engl J Med"},{"key":"1279_CR3","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1253\/circj.CJ-09-0254","volume":"73","author":"M Tsuchihashi-Makaya","year":"2009","unstructured":"Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H (2009) Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report From the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 73:1893\u20131900","journal-title":"Circ J"},{"key":"1279_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","volume":"362","author":"S Yusuf","year":"2003","unstructured":"Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362:777\u2013781","journal-title":"Lancet"},{"key":"1279_CR5","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456\u20132467","journal-title":"N Engl J Med"},{"key":"1279_CR6","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","volume":"27","author":"JG Cleland","year":"2006","unstructured":"Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27:2338\u20132345","journal-title":"Eur Heart J"},{"key":"1279_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","volume":"15","author":"K Yamamoto","year":"2013","unstructured":"Yamamoto K, Origasa H, Hori M (2013) Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). Eur J Heart Fail 15:110\u2013118","journal-title":"Eur J Heart Fail"},{"key":"1279_CR8","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","volume":"288","author":"DW Kitzman","year":"2002","unstructured":"Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP (2002) Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288:2144\u20132150","journal-title":"JAMA"},{"key":"1279_CR9","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/eurjhf\/hfr133","volume":"13","author":"PS Bhella","year":"2011","unstructured":"Bhella PS, Prasad A, Heinicke K, Hastings JL, Rbab-Zadeh A, Adams-Huet B, Pacini EL, Shibata S, Palmer MD, Newcomer BR, Levine BD (2011) Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 13:1296\u20131304","journal-title":"Eur J Heart Fail"},{"key":"1279_CR10","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa032566","volume":"350","author":"MR Zile","year":"2004","unstructured":"Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350:1953\u20131959","journal-title":"N Engl J Med"},{"key":"1279_CR11","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","volume":"115","author":"CS Lam","year":"2007","unstructured":"Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 115:1982\u20131990","journal-title":"Circulation"},{"key":"1279_CR12","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","volume":"124","author":"MR Zile","year":"2011","unstructured":"Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124:2491\u20132501","journal-title":"Circulation"},{"key":"1279_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/0735-1097(91)90832-T","volume":"17","author":"DW Kitzman","year":"1991","unstructured":"Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan MJ (1991) Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank\u2013Starling mechanism. J Am Coll Cardiol 17:1065\u20131072","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCHEARTFAILURE.112.000216","volume":"6","author":"MR Zile","year":"2013","unstructured":"Zile MR, Kjellstrom B, Bennett T, Cho Y, Baicu CF, Aaron MF, Abraham WT, Bourge RC, Kueffer FJ (2013) Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction. Circ Heart Fail 6:508\u2013516","journal-title":"Circ Heart Fail"},{"key":"1279_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","volume":"56","author":"MT Maeder","year":"2010","unstructured":"Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM (2010) Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 56:855\u2013863","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR16","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","volume":"15","author":"MM Abudiab","year":"2013","unstructured":"Abudiab MM, Redfield MM, Melenovsky V, Olson TP, Kass DA, Johnson BD, Borlaug BA (2013) Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 15:776\u2013785","journal-title":"Eur J Heart Fail"},{"key":"1279_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.amjcard.2004.11.006","volume":"95","author":"S Brucks","year":"2005","unstructured":"Brucks S, Little WC, Chao T, Kitzman DW, Wesley-Farrington D, Gandhi S, Shihabi ZK (2005) Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 95:603\u2013606","journal-title":"Am J Cardiol"},{"key":"1279_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jacc.2005.01.025","volume":"45","author":"H Dokainish","year":"2005","unstructured":"Dokainish H, Zoghbi WA, Lakkis NM, Ambriz E, Patel R, Quinones MA, Nagueh SF (2005) Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 45:1223\u20131226","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1253\/circj.CJ-08-0457","volume":"73","author":"H Okura","year":"2009","unstructured":"Okura H, Kubo T, Asawa K, Toda I, Yoshiyama M, Yoshikawa J, Yoshida K (2009) Elevated E\/E\u2032 predicts prognosis in congestive heart failure patients with preserved systolic function. Circ J 73:86\u201391","journal-title":"Circ J"},{"key":"1279_CR20","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/eurheartj\/ehu315","volume":"35","author":"S Dorfs","year":"2014","unstructured":"Dorfs S, Zeh W, Hochholzer W, Jander N, Kienzle RP, Pieske B, Neumann FJ (2014) Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction. Eur Heart J 35:3103\u20133112","journal-title":"Eur Heart J"},{"key":"1279_CR21","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin\u2013angiotensin\u2013aldosterone system. Circulation 83:1849\u20131865","journal-title":"Circulation"},{"key":"1279_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/hy1101.099484","volume":"38","author":"F Zannad","year":"2001","unstructured":"Zannad F, Dousset B, Alla F (2001) Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. Hypertension 38:1227\u20131232","journal-title":"Hypertension"},{"key":"1279_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.pcad.2005.02.001","volume":"47","author":"K Hogg","year":"2005","unstructured":"Hogg K, McMurray J (2005) Neurohumoral pathways in heart failure with preserved systolic function. Prog Cardiovasc Dis 47:357\u2013366","journal-title":"Prog Cardiovasc Dis"},{"key":"1279_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/eurheartj\/ehr292","volume":"33","author":"F Edelmann","year":"2012","unstructured":"Edelmann F, Tomaschitz A, Wachter R, Gelbrich G, Knoke M, Dungen HD, Pilz S, Binder L, Stahrenberg R, Schmidt A, Marz W, Pieske B (2012) Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J 33:203\u2013212","journal-title":"Eur Heart J"},{"key":"1279_CR25","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","volume":"106","author":"G Suzuki","year":"2002","unstructured":"Suzuki G, Morita H, Mishima T, Sharov VG, Todor A, Tanhehco EJ, Rudolph AE, McMahon EG, Goldstein S, Sabbah HN (2002) Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 106:2967\u20132972","journal-title":"Circulation"},{"key":"1279_CR26","doi-asserted-by":"publisher","first-page":"H175","DOI":"10.1152\/ajpheart.00660.2006","volume":"292","author":"D Susic","year":"2007","unstructured":"Susic D, Varagic J, Ahn J, Matavelli L, Frohlich ED (2007) Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. Am J Physiol Heart Circ Physiol 292:H175\u2013H179","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1279_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","volume":"110","author":"PM Mottram","year":"2004","unstructured":"Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH (2004) Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 110:558\u2013565","journal-title":"Circulation"},{"key":"1279_CR28","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2009.08.021","volume":"54","author":"GJ Mak","year":"2009","unstructured":"Mak GJ, Ledwidge MT, Watson CJ, Phelan DM, Dawkins IR, Murphy NF, Patle AK, Baugh JA, McDonald KM (2009) Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. J Am Coll Cardiol 54:1674\u20131682","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","volume":"17","author":"A Deswal","year":"2011","unstructured":"Deswal A, Richardson P, Bozkurt B, Mann DL (2011) Results of the randomized aldosterone antagonism in heart failure with preserved ejection fraction trial (RAAM-PEF). J Card Fail 17:634\u2013642","journal-title":"J Card Fail"},{"key":"1279_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/jama.2013.905","volume":"309","author":"F Edelmann","year":"2013","unstructured":"Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Loffler M, Dungen HD, Tschope C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B (2013) Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 309:781\u2013791","journal-title":"JAMA"},{"key":"1279_CR31","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cardfail.2014.05.010","volume":"20","author":"KM Kurrelmeyer","year":"2014","unstructured":"Kurrelmeyer KM, Ashton Y, Xu J, Nagueh SF, Torre-Amione G, Deswal A (2014) Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail 20:560\u2013568","journal-title":"J Card Fail"},{"key":"1279_CR32","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2016.07.763","volume":"68","author":"W Kosmala","year":"2016","unstructured":"Kosmala W, Rojek A, Przewlocka-Kosmala M, Wright L, Mysiak A, Marwick TH (2016) Effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 68:1823\u20131834","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR33","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1111\/jgs.14940","volume":"65","author":"B Upadhya","year":"2017","unstructured":"Upadhya B, Hundley WG, Brubaker PH, Morgan TM, Stewart KP, Kitzman DW (2017) Effect of spironolactone on exercise tolerance and arterial function in older adults with heart failure with preserved ejection fraction. J Am Geriatr Soc 65:2374\u20132382","journal-title":"J Am Geriatr Soc"},{"issue":"264\u20139","key":"1279_CR34","first-page":"W64","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(264\u20139):W64","journal-title":"Ann Intern Med"},{"key":"1279_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","volume":"22","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107\u2013133","journal-title":"J Am Soc Echocardiogr"},{"key":"1279_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1\u201312","journal-title":"Control Clin Trials"},{"key":"1279_CR37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"1279_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","volume":"45","author":"D Follmann","year":"1992","unstructured":"Follmann D, Elliott P, Suh I, Cutler J (1992) Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45:769\u2013773","journal-title":"J Clin Epidemiol"},{"key":"1279_CR39","doi-asserted-by":"publisher","first-page":"e002137","DOI":"10.1161\/JAHA.115.002137","volume":"4","author":"A Pandey","year":"2015","unstructured":"Pandey A, Garg S, Matulevicius SA, Shah AM, Garg J, Drazner MH, Amin A, Berry JD, Marwick TH, Marso SP, de Lemos JA, Kumbhani DJ (2015) Effect of mineralocorticoid receptor antagonists on cardiac structure and function in patients with diastolic dysfunction and heart failure with preserved ejection fraction: a meta-analysis and systematic review. J Am Heart Assoc 4:e002137","journal-title":"J Am Heart Assoc"},{"key":"1279_CR40","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","volume":"62","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147\u2013e239","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR41","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129\u20132200","journal-title":"Eur Heart J"},{"key":"1279_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/japplphysiol.00049.2015","volume":"119","author":"MJ Haykowsky","year":"2015","unstructured":"Haykowsky MJ, Tomczak CR, Scott JM, Paterson DI, Kitzman DW (2015) Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction. J Appl Physiol 119:739\u2013744","journal-title":"J Appl Physiol"},{"key":"1279_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","volume":"131","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O\u2019Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B (2015) Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial. Circulation 131:34\u201342","journal-title":"Circulation"},{"key":"1279_CR44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jacc.2004.09.059","volume":"45","author":"M Wang","year":"2005","unstructured":"Wang M, Yip G, Yu CM, Zhang Q, Zhang Y, Tse D, Kong SL, Sanderson JE (2005) Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 45:272\u2013277","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/eurheartj\/ehp498","volume":"31","author":"AS Sharp","year":"2010","unstructured":"Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV, Zambanini A, O\u2019Brien E, Chaturvedi N, Lyons S, Byrd S, Poulter NR, Sever PS, Mayet J (2010) Tissue Doppler E\/E\u2032 ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J 31:747\u2013752","journal-title":"Eur Heart J"},{"key":"1279_CR46","doi-asserted-by":"publisher","first-page":"243735","DOI":"10.1155\/2012\/243735","volume":"2012","author":"H Fukuta","year":"2012","unstructured":"Fukuta H, Ohte N, Wakami K, Goto T, Tani T, Kimura G (2012) Prognostic value of left ventricular diastolic dysfunction in patients undergoing cardiac catheterization for coronary artery disease. Cardiol Res Pract 2012:243735","journal-title":"Cardiol Res Pract"},{"key":"1279_CR47","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00380-018-1165-x","volume":"33","author":"B Han","year":"2018","unstructured":"Han B, Li Y, Dong Z, Wan Q, Shen H, Li J, Wei M, Shen C (2018) Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction. Heart Vessels 33:1149\u20131158","journal-title":"Heart Vessels."},{"key":"1279_CR48","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1067\/mhj.2001.113218","volume":"141","author":"BA Vakili","year":"2001","unstructured":"Vakili BA, Okin PM, Devereux RB (2001) Prognostic implications of left ventricular hypertrophy. Am Heart J 141:334\u2013341","journal-title":"Am Heart J"},{"key":"1279_CR49","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","volume":"292","author":"RB Devereux","year":"2004","unstructured":"Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B (2004) Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 292:2350\u20132356","journal-title":"JAMA"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-018-1279-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-018-1279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T19:12:48Z","timestamp":1570821168000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-018-1279-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s00380-018-1279-1","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,12]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Ohte has received lecture fees from Takeda Pharmaceutical Co. Ltd., Daiichi Sankyo Co., Ltd, Bayer GA, AstraZeneca plc, and Boehringer Ingelheim and grant support from Takeda Pharmaceutical Co. Ltd., Bayer GA, Daiichi Sankyo Co., Ltd, MSD, Novartis International AG, Boehringer Ingelheim, Astellas Pharma Inc., and Otsuka Pharmaceutical Co., Ltd. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}